Published in Eksp Klin Gastroenterol on January 01, 2009
[Rifaximin application in the overgrowth bacterial syndrome in the small intestine in patients after cholecystectomy]. Eksp Klin Gastroenterol (2011) 0.80
[The possibility of Helicobacter pylori being present in the resting state in the gastric mucosa of peptic acid patients after treatment]. Ter Arkh (1999) 0.76
Diagnostic methods for detecting forms and strains of Helicobacter pylori and evaluation of its eradication. Bull Exp Biol Med (2001) 0.76
[Eradication of Helicobacter pylori in patients with duodenal ulcer following the short course of treatment with azitromycin and amoxycillin]. Antibiot Khimioter (2002) 0.76
[Cytokine-related status in cholelithiasis and postcholecystectomy syndrome combined with peptic ulcer]. Eksp Klin Gastroenterol (2006) 0.75
[Cholelithiasis: approaches to solving the problem]. Ter Arkh (2005) 0.75
[Participation of gastroduodenal mucosa prostaglandins in the anti-ulcer effect of venter]. Biull Eksp Biol Med (1998) 0.75
[The experimental and clinical effect of ciprofloxacin on the microflora of the gastrointestinal tract]. Zh Mikrobiol Epidemiol Immunobiol (1991) 0.75
[Chronic abdominal pain syndrome in biliary pathology]. Eksp Klin Gastroenterol (2007) 0.75
[Effect of ursodeoxycholic acid on the characteristics of lipid metabolism in cholelithiasis and gall-bladder cholesterosis]. Eksp Klin Gastroenterol (2007) 0.75
[Outstanding, disputed, and unresolved issues in biliary pathology]. Eksp Klin Gastroenterol (2008) 0.75
[24-Hour pH monitoring for the evaluation of functional and morphological esophageal disorders in patients with duodenal ulcers]. Ross Gastroenterol Zh (2001) 0.75
[Particular features of the clinical course of ulcer in tobacco farmers from Kyrgyzstan]. Eksp Klin Gastroenterol (2007) 0.75
[Cholelithiasis associated with duodenal ulcer (literature review)]. Eksp Klin Gastroenterol (2008) 0.75
[Rationale for the allocation of clinical variants of the postcholecystectomical syndrome associated with bacterial overgrowth in the small intestine]. Eksp Klin Gastroenterol (2011) 0.75
[III Congress of the Scientific Society of Russian Gastroenterologists and XXIX Scientific Session of the Central Research Institute of Gastroenterology of the Moscow Health Committee]. Eksp Klin Gastroenterol (2002) 0.75
[Heterotopy of the mucous membrane in the fundic part of stomach into an adenomatous polyp of the common bile duct with an ulcerous affection formed in it]. Eksp Klin Gastroenterol (2004) 0.75
[Biliary pancreatitis]. Eksp Klin Gastroenterol (2005) 0.75
[Gallbladder adenomyomatosis]. Eksp Klin Gastroenterol (2010) 0.75
[Efficacy of rifaximine in small intestinal bacterial overgrowth syndrome in patients after cholecystectomy]. Ter Arkh (2011) 0.75
[Immunoglobulins in the mucous membrane of the stomach and duodenum in patients with peptic ulcer]. Ross Med Zh (1992) 0.75
[Sandpaper gallbladder and atherogenic dyslipidemia: a chain of successive events]. Eksp Klin Gastroenterol (2007) 0.75
[Campylobacter pylori and early relapse of peptic ulcer]. Vrach Delo (1989) 0.75
[Functional state of the biliary tract in cholelithiasis combined with duodenal ulcer according to the data of ultrasound examination]. Eksp Klin Gastroenterol (2008) 0.75
[The role of Campylobacter pyloridis in the etiology and pathogenesis of peptic ulcer]. Ter Arkh (1988) 0.75
[Endoscopic retrograde cholangiopancreatography: standards of the procedure]. Eksp Klin Gastroenterol (2009) 0.75
[Assessment of the efficacy of de-nol and bismuth subnitrate treatment of patients with associated peptic ulcer and pyloric Helicobacter infection (experimental and clinical studies)]. Ter Arkh (1991) 0.75
[Biliary deficiency and disorders of duodenal digestion]. Eksp Klin Gastroenterol (2004) 0.75
[Secretory immunoglobulin A and pyloric helicobacteriosis in patients with duodenal ulcer]. Arkh Patol (1991) 0.75
[Effects of antibiotics on the gastric mucosa and Helicobacter pylori in prolonged therapy]. Klin Med (Mosk) (1995) 0.75
[Endoscopic retrograde cholangiopancreatography: is it possible to effectively prevent ERCP-induced pancreatitis?]. Eksp Klin Gastroenterol (2008) 0.75
[Xanthogranulomatous cholecystitis (a literature review and an own case report)]. Eksp Klin Gastroenterol (2002) 0.75
[Isolation of Campylobacter pylori]. Sov Med (1990) 0.75
[Classification of cholelithiasis]. Ter Arkh (2004) 0.75
[Immunoglobulin G4-associated diseases of the digestive system--new problem in gastroenterology]. Eksp Klin Gastroenterol (2009) 0.75
[Bone metaplasia in the gallbladder wall]. Eksp Klin Gastroenterol (2011) 0.75
[Major achievements of biliary science for 40 years]. Eksp Klin Gastroenterol (2007) 0.75
[Efficiency of ursotherapy in cholesterol-associated pathology of the gallbladder]. Eksp Klin Gastroenterol (2009) 0.75
[Cytoprotective effect of ursodeoxycholic acid on the gastroduodenal zone mucous membrane at elderly patients with a combination of gallstone disease and duodenal ulcer]. Eksp Klin Gastroenterol (2011) 0.75
[10 years of cholelithiasis classification (Central Scientific Research Institute of Gastroenterology): highlights of scientific and practical applications]. Eksp Klin Gastroenterol (2012) 0.75
[Republican Scientific-Practical Conference "Diagnosis and Treatment of Ulcerative Disease at Outpatient Facilities and Polyclinics and at Therapeutic and Surgical Hospital Departments". April 25-26, 2002, Tver']. Eksp Klin Gastroenterol (2002) 0.75
[The role of the congenital duodenum abnormality in development of the upper gastrointestinal tract and the biliary system diseases]. Eksp Klin Gastroenterol (2009) 0.75
[Enzymatic cholecystitis]. Eksp Klin Gastroenterol (2009) 0.75
[Causes of biliary sludge]. Ter Arkh (2003) 0.75
[Forced resection of the liver right lobe in the patient with cholelithiasis]. Eksp Klin Gastroenterol (2012) 0.75
[Biliary pathology. Key aspects of the problem]. Eksp Klin Gastroenterol (2011) 0.75
[How realistic and effective is primary cholecystolithiasis prophylaxis?]. Eksp Klin Gastroenterol (2011) 0.75
[Dynamics and scientific prognosis of stomach cancer]. Eksp Klin Gastroenterol (2003) 0.75
[Disorders of bone mineral density in patients with cholelithiasis and postcholecystectomic syndrome]. Eksp Klin Gastroenterol (2010) 0.75
[Changes in concentration of cholecystokinin-pancreozymin in patients with cholelithiasis before and after cholecystectomy]. Eksp Klin Gastroenterol (2010) 0.75
[Remote results of cholecystectomy]. Eksp Klin Gastroenterol (2008) 0.75
[The problem of biliary sludge]. Klin Med (Mosk) (2003) 0.75
[Quantitative analysis of morphological manifestations of cholesterosis and concomitant pathology of the gall bladder]. Arkh Patol (2004) 0.75
[Gallbladder cholesterosis in patients with atherogenic dyslipidemia: pathogenesis, clinical picture, treatment]. Eksp Klin Gastroenterol (2008) 0.75
[Differential approach to detection and treatment of cholelithiasis in outpatient conditions]. Ter Arkh (2005) 0.75
[Campylobacter pyloridis in peptic ulcer]. Arkh Patol (1988) 0.75
[On the problem of classification of cholelithiasis]. Eksp Klin Gastroenterol (2004) 0.75
[Problems and prospects of studies of the Helicobacter pylori infection]. Eksp Klin Gastroenterol (2006) 0.75
[Bile acids in norm and pathology]. Eksp Klin Gastroenterol (2010) 0.75
[Chronic erosion of the stomach (clinico-morphologic study)]. Arkh Patol (1985) 0.75
[Clinicomorphological characteristics of the gallbladder cholesterosis based on materials from 345 cholecystectomies]. Eksp Klin Gastroenterol (2003) 0.75
[Helicobacter and biliary pathology]. Eksp Klin Gastroenterol (2006) 0.75
[Local and general humoral immunity in peptic ulcer patients]. Vrach Delo (1990) 0.75
[Some characteristics of various models of jet injectors]. Voen Med Zh (1973) 0.75
[Active chronic gastritis and Helicobacter pylori]. Arkh Patol (1994) 0.75
[Adenomyomatosis of the gallbladder the analysis of 328 operating cases]. Eksp Klin Gastroenterol (2013) 0.75
[State of local and total humoral immunity in duodenal ulcer with Campylobacter pylori infection]. Sov Med (1990) 0.75
[Pathogenetic and diagnostic aspects of postcholecystectomy syndrome]. Eksp Klin Gastroenterol (2009) 0.75
[Biochemical characteristics of operating bile composition in different types of cholecystolithiasis]. Eksp Klin Gastroenterol (2010) 0.75
[The intestinal microflora and acid-forming function of the stomach in peptic ulcer patients with Helicobacter pylori bacteriosis]. Zh Mikrobiol Epidemiol Immunobiol (1991) 0.75
[Mebeverine-retard in relief of pain in gallstone patients]. Eksp Klin Gastroenterol (2002) 0.75
[Experience in performing vaccination against smallpox by the needleless method]. Voen Med Zh (1969) 0.75
[Campylobacter pyloridis in duodenal ulcer]. Sov Med (1989) 0.75
[Diffuse thickening of the gallbladder wall. Clinical significance]. Eksp Klin Gastroenterol (2010) 0.75
[The substantiation of UDCA usage in functional disorders of biliary tract]. Eksp Klin Gastroenterol (2011) 0.75
[The combination of cholelithiasis, adenomyomatosis and xanthogranulomatous cholecystitis increases risk of gallbladder cancer]. Eksp Klin Gastroenterol (2012) 0.75
[Obesity as a risk factor of non-alcoholic fatty gallbladder disease (cholicyststeatosis, steatocholecystitis)]. Eksp Klin Gastroenterol (2009) 0.75
[Clinical significance of biliary sludge]. Ter Arkh (2009) 0.75
[Lymphoplasmocytic (IGG4-associated) cholecystitis developed in a case of prolonged gallbladder adenomyomatosis]. Eksp Klin Gastroenterol (2009) 0.75
[Pharmacoeconomic analysis of treatment of certain diseases of the digestive system]. Eksp Klin Gastroenterol (2011) 0.75
[Efficacy of rifaksimin in excessive bacterial growth syndrome after cholecystectomy]. Eksp Klin Gastroenterol (2010) 0.75
[Clinical effectiveness of ciprofloxacin in a female patient with peptic ulcer associated with Helicobacter infection]. Klin Med (Mosk) (1995) 0.75
[Diagnosis and treatment of syndrome of excessive bacterial growth in the small intestine]. Eksp Klin Gastroenterol (2010) 0.75
[Effect of ursodeoxycholic acid for reducing the deficit of vitamin D status and bone mineral density at gallstones]. Eksp Klin Gastroenterol (2010) 0.75